GRK2 and Hepatic fibrosis: Among these mechanisms, the association between G protein-coupled receptor kinase 2 (GRK2), an inhibitor of G protein-coupled receptor signaling, and Akt-mediated endothelial nitric oxide synthase (eNOS) activation has been reported in experimental models of liver fibrosis [3].